Position in NTRA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,079,556
+$242,798 QoQ
Shares Held
3,977
-4.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#435
of 844 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026EP Wealth Advisors, LLC holds $22,351,621 across 18 Diagnostics & Research names. NTRA ranks #5 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
15,882 | $7,962,599 | |
| 2 | DHR |
Danaher Corp /De/
|
19,985 | $3,806,742 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
4,367 | $2,298,963 | |
| 4 | A |
Agilent Technologies, Inc.
|
11,685 | $1,552,118 | |
| 5 | NTRA |
Natera, Inc.
This page
|
3,977 | $1,079,556 | |
| 6 | DGX |
Quest Diagnostics Inc
|
3,498 | $741,401 | |
| 7 | ILMN |
Illumina, Inc.
|
4,131 | $726,353 | |
| 8 | GH |
Guardant Health, Inc.
|
4,274 | $641,228 |
All Filings in NTRA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,079,556 | 3,977 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $836,758 | 4,184 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $535,383 | 2,337 | Shares | Sole | 2026-02-18 | |
| 2025-06-30 | $220,635 | 1,306 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $241,565 | 1,526 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||